Keros Therapeutics Inc (KROS) — Financial Flexibility Index
Keros Therapeutics Inc (KROS) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of $3.38 Million (operating CF $3.25 Million minus capex $132.00K) represents 0% of total liabilities ($39.20 Million). Also explore Keros Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Keros Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Keros Therapeutics Inc across 7 annual periods. Check Keros Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Keros Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Keros Therapeutics Inc. For the full company profile including market capitalisation, see Keros Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.59x | $-158.94 Million | $-160.87 Million | $44.33 Million | ▼ -11.1% |
| 2023 | -3.23x | $-122.04 Million | $-124.51 Million | $37.81 Million | ▼ -37.7% |
| 2022 | -2.34x | $-68.82 Million | $-70.06 Million | $29.36 Million | ▲ +53.7% |
| 2021 | -5.06x | $-61.12 Million | $-62.15 Million | $12.08 Million | ▼ -6.8% |
| 2020 | -4.74x | $-36.60 Million | $-36.89 Million | $7.72 Million | ▼ -65.9% |
| 2019 | -2.86x | $-15.73 Million | $-16.00 Million | $5.50 Million | ▼ -676.8% |
| 2018 | 0.50x | $7.26 Million | $7.04 Million | $14.65 Million | — |